Alternatives to Czechia – Medical consumables – Spotřební materiál pro hematologické analyzátory včetně výpůjčky

Czechia – Magnetic resonance unit – Magnetická rezonance

Czechia – Analgesics – Fremanezumab

Czechia – Medical consumables – Dodávky dialyzačních roztoků a spotřebního materiálu k přístroji multiFiltrate (PRO) a multifiltrate CiCa

Czechia – Diagnostic devices – Zajištění diagnostik pro imunoanalytické stanovení autoprotilátek - UKIA

Czechia – Artificial joints – Individuální onkologické implantáty

Czechia – Beds for medical use – Nákup 42 ks lůžek s laterálním náklonem, 81 ks lůžek polohovacích a 120 ks nočních stolků

Czechia – Antineoplastic and immunomodulating agents – Dodávky léčivých přípravků s účinnou látkou OFATUMUMAB 2026

Czechia – Surgical gloves – Operační a vyšetřovací rukavice 2025

Czechia – Pharmaceutical products – DYNAMICKÝ NÁKUPNÍ SYSTÉM NA DODÁVKY LÉČIVÝCH PŘÍPRAVKŮ, VÝŽIV A VYBRANÝCH ZDRAVOTNICKÝCH PROSTŘEDKŮ

Czechia – Laboratory reagents – Dodávka laboratorního materiálu – laboratorních kitů, chemikálií a laboratorního plastu v letech 2025 až 2026

Expected Outcome: the proposals under this call are expected to address one or more of the following subjects : • Enhanced personalized monitoring, care and treatments, focusing on the development of highly customized healthcare solutions, including the required research and diagnostic tools, tailored to individual needs, covering various scenarios such as chronic disease management, physiotherapy, precision diagnosis, personalized medicine/treatment, pre- and postoperative care, and daily assistance in homes and common spaces. It also targets effective management of chronic diseases and elderly care through personalized monitoring and interventions facilitated by advanced sensor technologies and edge-to-cloud solutions. This includes the development and integration of solutions for Hospitalization at Home, enabling patients to receive complex, remotely supervised care using intelligent medical devices capable of sensing, analysing, and transmitting real-time data. This requires a continuum, from in-hospital diagnostics to robust, long-term patient support at home via AI-driven care pathways and hospitalization at home. • Prevention and treatment of diseases, allowing the improved…

Expected Outcome: Proposals submitted to this call are expected to address several of the following elements: • Scaling of wafer-level photonic processes for key materials (e.g. SiN, InP, GaAs),including process integration, yield optimisation, and manufacturability at highvolumes. • Development of packaging and test solutions that are scalable, automated, andcompatible with co-packaged optics and advanced photonic-electronic integration. • Integration of heterogeneous materials and components, such as on-chip lasers,modulators, and detectors, using advanced packaging and assembly approaches. • Design-process-equipment co-optimisation, enabling repeatable, cost-effectiveproduction of complex photonic circuits and systems, including use of PDKs andvalidated building blocks. • Demonstration of system-level functionality through application-relevant use casesin strategic sectors (e.g. AI, sensing, telecommunication, mobility, health, defence),with quantified performance metrics and clear market relevance.